Partnering with another biotech company in the field is a great strategy to share the risk of new drug discovery, and a method to bring cash into the discovery phase for the enterprise. Insurance, also, is extremely important, as the pharmaceutical industry is a risky business with rampant technical failure. The key for safeguarding the business is to think proactively, seek out shared partnerships (the case study quoted here, by Cytokinetics’ CEO Jim Sabry, is a deal with drug maker Angen) and to invest in multiple products along a realistic timeline.
Related
Lisa Alderson,
Genome Medical
Dare to Stretch Your Boundaries [Entire Talk]
Get out of your comfort zone and learn to be adaptable. Breakthroughs don't come from doing what you've always done.
Lisa Alderson,
Genome Medical
Dare to Stretch Your Boundaries [Entire Talk]
Get out of your comfort zone and learn to be adaptable. Breakthroughs don't come from doing what you've always done.
Gabriel Parisi-Amon,
Nebia Shower
A Burnout Manifesto [Entire Talk]
Allow yourself to pause work so you can reflect and decompress. The source of protection from burnout is grounded in your values.
Gabriel Parisi-Amon,
Nebia Shower
A Burnout Manifesto [Entire Talk]
Allow yourself to pause work so you can reflect and decompress. The source of protection from burnout is grounded in your values.
Tracy Chou,
Project Include
Debugging the Brogrammer Culture [Entire Talk]
Constantly ask yourself, 'Who's not in the room?" Championing diversity in tech will result in a more inclusive culture and better products.
Tracy Chou,
Project Include
Debugging the Brogrammer Culture [Entire Talk]
Constantly ask yourself, 'Who's not in the room?" Championing diversity in tech will result in a more inclusive culture and better products.
